Martin Schaller
Martin Schaller is an expert in Dermatology at Universitätsklinikum Tübingen (Germany). As of October 2026, ScienceLeadR ranks Martin Schaller in the top 1% of experts worldwide for Rosacea. Martin Schaller has authored 449 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 1,102 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Infectiology - Cardiology - Medical Imaging
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1995 - 2026
Number : 449
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Persistent SARS-CoV-2 Spike Protein in Vasculitic Skin Lesions after Infection or mRNA Vaccination: A Retrospective Case control Immunofluorescence Study. PMID 42516097 — skin, cells, sexually transmitted diseases, vasculitis, sars-cov-2, vaccines, rna, messenger, vaccination, vasculitis, leukocytoclastic, cutaneous, covid-19, endothelial cells, viral proteins, severe acute respiratory syndrome-related coronavirus, wounds and injuries, dermatology, infections | Acta Derm Venereol | 2026 | 1 |
| A PET reporter ligand for quantitative imaging of gene expression in the brain. PMID 42509348 — genes, brain, biomedical engineering, ligands, gene expression | Nat Biomed Eng | 2026 | 0 |
| Preclinical evaluation of [ 18F]fluoroethylresorufin as PET tracer for cerebral amyloid angiopathy. PMID 42458180 — brain, amyloid, tissues, cerebral amyloid angiopathy, preclinical evaluation | EJNMMI Res | 2026 | 0 |
| Consensus-based Guideline on tinea capitis. PMID 42444404 — terbinafine, skin diseases, tinea capitis, therapeutics, arthrodermataceae, tinea, infections | J Dtsch Dermatol Ges | 2026 | 0 |
| Large Core Stroke Thrombectomy Is Safe and Effective Regardless of Prior Antithrombotic or Thrombolytic Treatment: A Secondary Analysis of the Randomized TENSION Trial. PMID 42261979 — anticoagulants, heart diseases, safety, hemorrhage, ischemic stroke, stroke, intracranial hemorrhages, therapeutics, thrombectomy | J Am Heart Assoc | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map